Sorrentino, V.G.; Thota, S.; Gonzalez, E.A.; Rameshwar, P.; Chang, V.T.; Etchegaray, J.-P.
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. Pharmaceuticals 2021, 14, 641.
https://doi.org/10.3390/ph14070641
AMA Style
Sorrentino VG, Thota S, Gonzalez EA, Rameshwar P, Chang VT, Etchegaray J-P.
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. Pharmaceuticals. 2021; 14(7):641.
https://doi.org/10.3390/ph14070641
Chicago/Turabian Style
Sorrentino, Vincent G., Srijan Thota, Edward A. Gonzalez, Pranela Rameshwar, Victor T. Chang, and Jean-Pierre Etchegaray.
2021. "Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia" Pharmaceuticals 14, no. 7: 641.
https://doi.org/10.3390/ph14070641
APA Style
Sorrentino, V. G., Thota, S., Gonzalez, E. A., Rameshwar, P., Chang, V. T., & Etchegaray, J. -P.
(2021). Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. Pharmaceuticals, 14(7), 641.
https://doi.org/10.3390/ph14070641